Trial Status:
Closed
Purpose:
To evaluate the effects of GB001 in individuals with chronic rhinosinusitis (CRS).
Participants:
- 8-75 years old
- Dx of CRSwNP or CRSsNP 12 wks prior
- Undergone polyp surgery w/n 4 months
Link:
Principal Investigator:
Research Area:
Clinical and Population Research